MARKET

LCTX

LCTX

Lineage Cell The
AMEX
1.305
+0.025
+1.95%
Opening 14:23 06/02 EDT
OPEN
1.275
PREV CLOSE
1.280
HIGH
1.325
LOW
1.264
VOLUME
356.63K
TURNOVER
191.76K
52 WEEK HIGH
1.790
52 WEEK LOW
1.020
MARKET CAP
222.08M
P/E (TTM)
-9.4156
1D
5D
1M
3M
1Y
5Y
Russell 3000 rejig: InMode, Assertio among healthcare additions; Inovio, Bionano among deletions
Seeking Alpha · 05/24 17:57
BRIEF-Lineage Cell Therapeutics Expected To Be Added To Russell 3000 Index
Reuters · 05/22 12:41
Lineage Cell The: Current report
Press release · 05/18 17:28
Lineage Cell The: Prospectus [Rule 424(b)(5)]
Press release · 05/18 17:27
Lineage Therap (LCTX) Receives a Buy from Robert W. Baird
TipRanks · 05/15 10:06
Lineage Therap (LCTX) Gets a Buy from Maxim Group
TipRanks · 05/13 17:55
HC Wainwright & Co. Reiterates Lineage Cell Therapeutics (LCTX) Buy Recommendation
NASDAQ · 05/12 17:45
H.C. Wainwright Reaffirms Their Buy Rating on Lineage Therap (LCTX)
TipRanks · 05/12 10:15
More
About LCTX
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing cell therapies to address unmet medical needs. It designs, develops, and manufactures specialized human cells with anatomical and physiological functions which are similar or identical to cells found naturally in the human body. It has five allogeneic product candidates: OpRegen, OPC1, VAC2, ANP1, and PNC1. OpRegen is a retinal pigment epithelium (RPE) cell replacement therapy in a Phase IIa development for the treatment of geographic atrophy secondary to age-related macular degeneration (AMD). OPC1 is an oligodendrocyte progenitor cell therapy in a Phase I/IIa development for the treatment of acute spinal cord injuries (SCI); VAC is a dendritic cell therapy produced from Lineages VAC technology platform for immuno-oncology and infectious disease, in Phase I clinical development for the treatment of non-small cell lung cancer.

Webull offers kinds of Lineage Cell Therapeutics Inc stock information, including AMEX:LCTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LCTX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LCTX stock methods without spending real money on the virtual paper trading platform.